Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is a 12-week, randomized, multicenter, double-blind, active-controlled, non-inferiority
study (TATPITA20101005) to compare the efficacy and safety of pitavastatin (Livalo®) and
atorvastatin (Lipitor®) in high risk hypercholesterolemic patients.